about
Enhanced response of T cells from murine gammaherpesvirus 68-infected mice lacking the suppressor of T cell receptor signaling molecules Sts-1 and Sts-2Interplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the HostInhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency.Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3.Inhibition of NF-kappaB signaling reduces virus load and gammaherpesvirus-induced pulmonary fibrosisShort duration of elevated vIRF-1 expression during lytic replication of human herpesvirus 8 limits its ability to block antiviral responses induced by alpha interferon in BCBL-1 cells.A gammaherpesvirus 68 gene 50 null mutant establishes long-term latency in the lung but fails to vaccinate against a wild-type virus challenge.Absence of the uracil DNA glycosylase of murine gammaherpesvirus 68 impairs replication and delays the establishment of latency in vivo.Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acidMurine Gammaherpesvirus 68 Pathogenesis Is Independent of Caspase-1 and Caspase-11 in Mice and Impairs Interleukin-1β Production upon Extrinsic Stimulation in Culture.The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus productionTiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection.Role of endoplasmic reticulum stress in age-related susceptibility to lung fibrosisA gammaherpesvirus-secreted activator of Vbeta4+ CD8+ T cells regulates chronic infection and immunopathology.The absence of M1 leads to increased establishment of murine gammaherpesvirus 68 latency in IgD-negative B cells.Complexities of gammaherpesvirus transcription revealed by microarrays and RNAseq.Ablation of STAT3 in the B Cell Compartment Restricts Gammaherpesvirus Latency In Vivo.NF-kappaB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency.Gammaherpesviral gene expression and virion composition are broadly controlled by accelerated mRNA degradation.Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines.A codon-shuffling method to prevent reversion during production of replication-defective herpesvirus stocks: Implications for herpesvirus vaccines.Roseolovirus molecular biology: recent advancesRoseoloviruses: unmet needs and research priorities: perspective.RTA Occupancy of the Origin of Lytic Replication during Murine Gammaherpesvirus 68 Reactivation from B Cell Latency.Impact of Adenovirus E4-ORF3 Oligomerization and Protein Localization on Cellular Gene Expression.Sequence requirements for interaction of human herpesvirus 7 origin binding protein with the origin of lytic replication.The replication and transcription activator of murine gammaherpesvirus 68 cooperatively enhances cytokine-activated, STAT3-mediated gene expression.U94, the human herpesvirus 6 homolog of the parvovirus nonstructural gene, is highly conserved among isolates and is expressed at low mRNA levels as a spliced transcript.Viral FGARAT ORF75A promotes early events in lytic infection and gammaherpesvirus pathogenesis in mice.Editorial overview: Roseoloviruses: stopping to smell the roses--the Roseoloviruses have come of age as human pathogens.Combinatorial Loss of the Enzymatic Activities of Viral Uracil-DNA Glycosylase and Viral dUTPase Impairs Murine Gammaherpesvirus Pathogenesis and Leads to Increased Recombination-Based Deletion in the Viral GenomeDifferences in DNA Binding Specificity among Roseolovirus Origin Binding Proteins
P50
Q27318672-5E754E60-3687-4902-80D7-9512D79958F8Q28080198-39A55656-B9E3-44FA-BED2-E2C4D0923D1CQ33270518-95349787-93A6-4B92-9FD4-7AD38A8CAB77Q33677823-1239810A-6B8B-4B48-AE7B-C102D41B8A1CQ34033532-3DDD0DF8-9339-4C09-A174-E03741E943AFQ34192731-EF5D28BD-0F6C-4C49-AB2B-3BC9A6C81EF6Q34302056-4CC6B8FD-93A1-43D4-8283-1D6DC9C1AD7AQ35111048-CB3E3DB1-2E64-4356-92DA-857F92E55872Q35702343-AB512B87-F69B-4656-A69B-C24875E43824Q35745447-5BDA480D-E9E6-4630-A651-12E398485827Q35847738-5928065A-6EA9-45B7-AC7B-8CF34B5373B0Q35867993-0472E444-6046-4EA4-939A-1D07E5F0AFC0Q36049753-D81B777E-15E6-4FB3-B0BD-387FA865C453Q36509873-82BCD78B-7E40-416F-9C17-614288051D4DQ36667866-D98FF5F1-B993-4D03-A517-8D936647C16DQ37018410-88382439-E8C6-42DD-8F9D-B996B780FE55Q37168674-B8B52B9A-DC85-43C7-A4AD-8DA0693F611CQ37192183-1E8DEDAD-1FAB-415E-B967-D75EDACE2AE1Q37488124-3A81AA30-562B-497A-A58F-DE203AEE3C93Q37683015-DC88A0B5-9C81-4528-AAAF-3E70BECFAFAFQ37695694-2C5BA57C-1CFB-4B8D-8635-6A9AC1B14BDCQ38273230-D566CD4C-C08D-4A22-A2B5-2021FB83B922Q38280952-FD2508D8-E40E-4C9A-A5C6-BA3F1F6F7D1DQ38716029-AF8E6460-F6C1-4E07-ACBA-30E1854DEC57Q38873678-01EC48BC-4597-4975-8FE9-D8DA4BB62133Q39606006-02CE4DD0-D6E6-4A54-B34E-8E549FBBC3F5Q40077951-AA12D1B2-4D7B-4CA0-8543-BE0429CCF732Q42620634-C02A8E47-1295-4226-A54E-76536A3BDA58Q47547149-31709166-9B52-4C24-BA55-4E4003B694AAQ51785971-00B42E26-ADB1-4245-AF1F-E7668E02109FQ58097213-55C4E576-8EAF-4ADD-8D79-0756F2D81D98Q62577949-03BC3E09-2977-4E71-8B79-2953649B7069
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Laurie T. Krug
@ast
Laurie T. Krug
@en
Laurie T. Krug
@es
Laurie T. Krug
@nl
Laurie T. Krug
@sl
type
label
Laurie T. Krug
@ast
Laurie T. Krug
@en
Laurie T. Krug
@es
Laurie T. Krug
@nl
Laurie T. Krug
@sl
altLabel
Laurie Krug
@en
prefLabel
Laurie T. Krug
@ast
Laurie T. Krug
@en
Laurie T. Krug
@es
Laurie T. Krug
@nl
Laurie T. Krug
@sl
P106
P1153
7003667012
P21
P2798
P31
P496
0000-0002-9648-522X